{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:57:26Z","timestamp":1794074246824,"version":"4.8.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003748","name":"Swedish Society for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018713","name":"Center for Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jhepr.2025.101365","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:26:14Z","timestamp":1740158774000},"page":"101365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Towards precision medicine strategies using plasma proteomic profiling for suspected gallbladder cancer: A pilot study"],"prefix":"10.1016","volume":"7","author":[{"given":"Ghada","family":"Nouairia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Cornillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Jansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Bergquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Sparrelid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2025.101365_bib1","doi-asserted-by":"crossref","first-page":"12653","DOI":"10.3748\/wjg.v21.i44.12653","article-title":"Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma: an analysis of 42 cases","volume":"21","author":"Deng","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101365_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijsu.2017.07.046","article-title":"Differentiation between gallbladder cancer with acute cholecystitis: considerations for surgeons during emergency cholecystectomy, a cohort study","volume":"45","author":"Kim","year":"2017","journal-title":"Int J Surg"},{"key":"10.1016\/j.jhepr.2025.101365_bib3","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.3748\/wjg.v26.i22.2967","article-title":"Benign gallbladder diseases: imaging techniques and tips for differentiating with malignant gallbladder diseases","volume":"26","author":"Yu","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101365_bib4","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1007\/s11605-023-05698-6","article-title":"Surgical and oncological outcomes of wedge resection versus segment 4b + 5 resection for T2 and T3 gallbladder cancer: a meta-analysis","volume":"27","author":"Matsui","year":"2023","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jhepr.2025.101365_bib5","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035805","article-title":"The utility of systemic immune inflammatory index in discriminating between gallbladder cancer and xanthogranulomatous cholecystitis: a single-tertiary center experience","volume":"102","author":"Dincer","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jhepr.2025.101365_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12957-023-02941-x","article-title":"The value of CT findings combined with inflammatory indicators for preoperative differentiation of benign and malignant gallbladder polypoid lesions","volume":"21","author":"Zhang","year":"2023","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.jhepr.2025.101365_bib7","article-title":"Machine learning-based radiological features and diagnostic predictive model of xanthogranulomatous cholecystitis","volume":"12","author":"Zhou","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jhepr.2025.101365_bib8","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.3748\/wjg.v20.i14.4085","article-title":"Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer","volume":"20","author":"Wang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101365_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12014-023-09399-9","article-title":"Proteomic analysis identifies dysregulated proteins and associated molecular pathways in a cohort of gallbladder cancer patients of African ancestry","volume":"20","author":"Baichan","year":"2023","journal-title":"Clin Proteomics"},{"key":"10.1016\/j.jhepr.2025.101365_bib10","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.bbrc.2014.03.017","article-title":"Identification of prosaposin and transgelin as potential biomarkers for gallbladder cancer using quantitative proteomics","volume":"446","author":"Sahasrabuddhe","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhepr.2025.101365_bib11","first-page":"853","article-title":"Proteomic-based analysis for identification of potential serum biomarkers in gallbladder cancer","volume":"26","author":"Tan","year":"2011","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jhepr.2025.101365_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02923-7","article-title":"Plasma-derived candidate biomarkers for detection of gallbladder carcinoma","volume":"11","author":"Priya","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2025.101365_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1046974","article-title":"Quantitative tissue proteome profile reveals neutrophil degranulation and remodeling of extracellular matrix proteins in early stage gallbladder cancer","volume":"12","author":"Akhtar","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.jhepr.2025.101365_bib14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12885-023-10840-3","article-title":"Tissue proteome analysis for profiling proteins associated with lymph node metastasis in gallbladder cancer","volume":"23","author":"Jain","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jhepr.2025.101365_bib16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41592-018-0019-x","article-title":"The curse(s) of dimensionality","volume":"15","author":"Altman","year":"2018","journal-title":"Nat Methods"},{"key":"10.1016\/j.jhepr.2025.101365_bib17","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cels.2021.06.006","article-title":"Artificial intelligence for proteomics and biomarker discovery","volume":"12","author":"Mann","year":"2021","journal-title":"Cell Syst"},{"key":"10.1016\/j.jhepr.2025.101365_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45323-9","article-title":"Application of statistical machine learning in biomarker selection","volume":"13","author":"Vashistha","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2025.101365_bib19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.euprot.2015.08.001","article-title":"Bayesian methods for proteomic biomarker development","volume":"9","author":"Hern\u00e1ndez","year":"2015","journal-title":"EuPA Open Proteomics"},{"key":"10.1016\/j.jhepr.2025.101365_bib20","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/acs.jproteome.1c00859","article-title":"Challenges and opportunities for Bayesian statistics in proteomics","volume":"21","author":"Crook","year":"2022","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jhepr.2025.101365_bib21","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2471\/BLT.07.045120","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"85","author":"von Elm","year":"2007","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jhepr.2025.101365_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1373\/jalm.2018.027086","article-title":"Reproducibility and variability of protein analytes measured using a multiplexed modified aptamer assay","volume":"4","author":"Tin","year":"2019","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.jhepr.2025.101365_bib23","unstructured":"Gene Set Knowledge Discovery with Enrichr - Xie - 2021 - Current Protocols - Wiley Online Library. https:\/\/currentprotocols.onlinelibrary.wiley.com\/doi\/10.1002\/cpz1.90 (Accessed July 10, 2024)."},{"key":"10.1016\/j.jhepr.2025.101365_bib24","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: a graphical gene-set enrichment tool for animals and plants","volume":"36","author":"Ge","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jhepr.2025.101365_bib25","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1093\/bioinformatics\/btab114","article-title":"A variable selection approach for highly correlated predictors in high-dimensional genomic data","volume":"37","author":"Zhu","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jhepr.2025.101365_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015004","article-title":"Aptamer-based multiplexed proteomic technology for biomarker discovery","volume":"5","author":"Gold","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2025.101365_bib27","unstructured":"ELISA Kit Search | Biocompare. https:\/\/www.biocompare.com\/pfu\/110627\/soids\/2-74765\/ELISA_Kit (Accessed July 4, 2024)."},{"key":"10.1016\/j.jhepr.2025.101365_bib28","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3389\/fonc.2020.01124","article-title":"Prognostic and clinicopathological significance of X-box-binding protein 1 and N-acetyltransferase 1 in gallbladder cancer","volume":"10","author":"Liu","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jhepr.2025.101365_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1124\/pr.110.004275","article-title":"Arylamine N-acetyltransferase 1: a novel drug target in cancer development","volume":"64","author":"Butcher","year":"2012","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jhepr.2025.101365_bib30","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00204-021-03194-x","article-title":"Identification and characterization of potent, selective, and efficacious inhibitors of human arylamine N-acetyltransferase 1","volume":"96","author":"Leggett","year":"2022","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.jhepr.2025.101365_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13045-022-01310-7","article-title":"Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy","volume":"15","author":"Liu","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jhepr.2025.101365_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11010-010-0562-y","article-title":"Vascular endothelial growth factor-C promotes the growth and invasion of gallbladder cancer via an autocrine mechanism","volume":"345","author":"Chen","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jhepr.2025.101365_bib33","first-page":"593","article-title":"Histidine rich glycoprotein and cancer: a multi-faceted relationship","volume":"34","author":"Johnson","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jhepr.2025.101365_bib34","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1158\/1535-7163.MCT-18-0097","article-title":"Leukocyte differentiation by histidine-rich glycoprotein\/stanniocalcin-2 complex regulates murine glioma growth through modulation of antitumor immunity","volume":"17","author":"Roche","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jhepr.2025.101365_bib35","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1186\/s12885-018-4651-8","article-title":"Classification of gallbladder cancer by assessment of CD8+ TIL and PD-L1 expression","volume":"18","author":"Lin","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jhepr.2025.101365_bib36","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/s41467-022-29164-0","article-title":"Single-cell transcriptomic analysis suggests two molecularly distinct subtypes of intrahepatic cholangiocarcinoma","volume":"13","author":"Song","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhepr.2025.101365_bib37","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3390\/cancers16071387","article-title":"Oncogenic STAT transcription factors as targets for cancer therapy: innovative strategies and clinical translation","volume":"16","author":"Wang","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.jhepr.2025.101365_bib38","doi-asserted-by":"crossref","first-page":"13876","DOI":"10.18632\/aging.202982","article-title":"Prognostic value of members of NFAT family for pan-cancer and a prediction model based on NFAT2 in bladder cancer","volume":"13","author":"Dai","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jhepr.2025.101365_bib39","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/nrc2735","article-title":"NFAT proteins: emerging roles in cancer progression","volume":"9","author":"Mancini","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jhepr.2025.101365_bib40","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ijc.21683","article-title":"Gallbladder cancer worldwide: geographical distribution and risk factors","volume":"118","author":"Randi","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jhepr.2025.101365_bib41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12029-011-9284-y","article-title":"Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates","volume":"43","author":"Rustagi","year":"2012","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.jhepr.2025.101365_bib42","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.11.019","article-title":"Gallbladder disease in patients with primary sclerosing cholangitis","volume":"48","author":"Said","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101365_bib43","first-page":"1","article-title":"Developing survival prediction models in colorectal cancer using epigenome-wide DNA methylation data from whole blood","volume":"8","author":"Fan","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.jhepr.2025.101365_bib44","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1245\/s10434-022-11383-w","article-title":"Lipid metabolism in biliary tract cancer: a new therapeutic target?","volume":"29","author":"Kerekes","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jhepr.2025.101365_bib45","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1476-4598-13-224","article-title":"C10ORF10\/DEPP, a transcriptional target of FOXO3, regulates ROS-sensitivity in human neuroblastoma","volume":"13","author":"Salcher","year":"2014","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jhepr.2025.101365_bib46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cotox.2017.11.014","article-title":"Oxidative stress in carcinogenesis","volume":"7","author":"Klaunig","year":"2018","journal-title":"Curr Opin Toxicol"},{"key":"10.1016\/j.jhepr.2025.101365_bib47","first-page":"425","article-title":"Preferential expression of cystein-rich secretory protein-3 (CRISP-3) in chronic pancreatitis","volume":"18","author":"Liao","year":"2003","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.jhepr.2025.101365_bib48","article-title":"New insights on the role of vascular endothelial growth factor in biliary pathophysiology","volume":"3","author":"Mariotti","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101365_bib49","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3390\/ijms18020418","article-title":"Targeting angiogenesis in biliary tract cancers: an open option","volume":"18","author":"Simone","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhepr.2025.101365_bib50","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.3389\/fimmu.2019.02854","article-title":"WNT signaling in tumors: the way to evade drugs and immunity","volume":"10","author":"Martin-Orozco","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2025.101365_bib51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ccr.2010.11.009","article-title":"HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF","volume":"19","author":"Rolny","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhepr.2025.101365_bib52","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.canlet.2021.10.034","article-title":"Wnt signaling pathway in cancer immunotherapy","volume":"525","author":"Zhou","year":"2022","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jhepr.2025.101365_bib53","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.3390\/cancers14194866","article-title":"CD8A as a prognostic and immunotherapy predictive biomarker can be evaluated by MRI radiomics features in bladder cancer","volume":"14","author":"Zheng","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jhepr.2025.101365_bib54","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.7150\/jca.53983","article-title":"Identification of cysteine protease inhibitor CST2 as a potential biomarker for colorectal cancer","volume":"12","author":"Xie","year":"2021","journal-title":"J Cancer"},{"key":"10.1016\/j.jhepr.2025.101365_bib55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.livres.2022.07.002","article-title":"Dynactin 2 acts as an oncogene in hepatocellular carcinoma through promoting cell cycle progression","volume":"6","author":"Li","year":"2022","journal-title":"Liver Res"},{"key":"10.1016\/j.jhepr.2025.101365_bib56","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1186\/s12885-020-07676-6","article-title":"Immunoproteomics approach revealed elevated autoantibody levels against ANXA1 in early stage gallbladder carcinoma","volume":"20","author":"Akhtar","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jhepr.2025.101365_bib59","doi-asserted-by":"crossref","first-page":"797","DOI":"10.21037\/jgo.2016.09.01","article-title":"Molecular profiling of biliary tract cancer: a target rich disease","volume":"7","author":"Jain","year":"2016","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.jhepr.2025.101365_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1169537","article-title":"Preoperative immunological plasma markers TRAIL, CSF1 and TIE2 predict survival after resection for biliary tract cancer","volume":"13","author":"Jansson","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.jhepr.2025.101365_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101510","article-title":"Key signal transduction pathways and crosstalk in cancer: biological and therapeutic opportunities","volume":"26","author":"Fu","year":"2022","journal-title":"Transl Oncol"},{"key":"10.1016\/j.jhepr.2025.101365_bib62","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jhepr.2025.101365_bib63","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/carcin\/bgab075","article-title":"JAK\/STAT of all trades: linking inflammation with cancer development, tumor progression and therapy resistance","volume":"42","author":"Sabaawy","year":"2021","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jhepr.2025.101365_bib64","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12964-022-00890-8","article-title":"Cholecystectomy promotes colon carcinogenesis by activating the Wnt signaling pathway by increasing the deoxycholic acid level","volume":"20","author":"Yao","year":"2022","journal-title":"Cell Commun Signal"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925000424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555925000424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T07:56:45Z","timestamp":1749196605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555925000424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2589555925000424"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101365","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards precision medicine strategies using plasma proteomic profiling for suspected gallbladder cancer: A pilot study","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101365"}}